Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Why Cannabis Companies (and Investors) Should Be Focused On Women, With Exclusive CEO Interview -- CFN Media


Posted on: 27 Jun 18

SEATTLE, June 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article and video interview covering 48North Cannabis Corp. (TSX-V:NRTH) which recently went public as the first cannabis company to focus on female consumers. The company aims to become the trusted ally of women making a meaningful impact on their health and wellness with innovative, trusted, cannabis-based products created through joint ventures with leading consumer packaged goods companies and their already-trusted brands.

Women control about $30 trillion in annual spending in categories ranging from home purchases to automobiles, but most companies still either ignore the demographic or patronize them by focusing on stereotypes.

The cannabis industry is no different despite indications that female consumption is on the rise. Some studies have found that women have surpassed men in cannabis consumption, while they also control about 85 percent of health and wellness spending.

Let’s take a closer look at why cannabis companies, and investors, should be focused on when and some opportunities in the space.

How Women Have Become Leading Cannabis Consumers

Most people assume that men make up the majority of cannabis consumption, but new surveys are starting to challenge that assumption.

The Cannabis Consumers Coalition (CCC) found that 53 percent of women have used cannabis compared to just 42 percent of men. The report follows a 2013 Gallup poll that found a narrowing gender gap with eight percent of men and six percent of women saying they’ve used cannabis on a daily basis. These surveys suggest that female cannabis consumers are growing at a faster rate than male consumers.

Women could also have a greater influence on cannabis purchases than men. According to HBR, women control nearly $30 trillion in annual consumer spending and contribute about $18 trillion in yearly earnings to household income. Women make the decision in the purchases of 94 percent of home furnishings, 92 percent of vacations, 91 percent of homes, 60 percent of automobiles, and 51 percent of consumer electronics.

How Do Women Consume Cannabis?

BDS Analytics surveyed more than 1,000 women across four states where cannabis sales are legal to see how they’re using the drug. In December 2017, the results were published in the Women’s Health Consumer Insights Survey.

The results may be somewhat surprising:

  • More than half of those surveyed use cannabis at least once a week.
  • Two-thirds of those surveyed were mothers with children at home.
  • Nearly half of women used cannabis for medicinal purposes, with more than half being mothers with children under 18 living at home.
  • About half of those surveyed use cannabis as a natural alternative to mood swings and sleep issues due to menstruation, menopause, or mental health conditions.
  • Women between 21-35 years old were more likely to purchase inhaled cannabis products, while those aged 35 and older preferred edible and topical products.
  • Women that use cannabis recreationally primarily consume cannabis to enhance their sexual experiences.

Cannabis flower remains the most preferred by of cannabis consumption with 35 percent of women using it, but these trends are likely to change as cannabis consumer packaged products become more ubiquitous and brands start to emerge.

How to Capitalize on These Trends

It’s no secret that most companies target male consumers. For instance, the vast majority of automobile ads feature speed and performance rather than convenience when hauling around small children -- and that’s despite women making 60 percent of automobile purchasing decisions!

The same is true within the cannabis industry: Many companies fail to realize the rising number of women using cannabis and the purchasing power that they have when it comes to their household -- and not to mention their parents and children.

CFN Media recently spoke with CEO Alison Gordon about the company’s focus and where it’s headed within the industry: Please Click Here to See Video

CEO Alison Gordon became the first female CEO of a publicly-traded cannabis company in early-June when shares began trading on the Canadian Stock Exchange. After working in both Canada and California, she recognized that the industry was heading from production footprints to a consumer branding focused and began positioning the company as a leader.

While the company will never be the leading producer in the space in terms of kilograms of dried cannabis per year, the team is already in discussions with consumer brands outside of the cannabis industry that are interested in the space. By joint venturing with these companies, and offering their production footprint and cannabis expertise, the company hopes to build relationships with consumers early on and launch leading health and wellness brands.

For more information, visit the company’s website at www.48nrth.com.  

Please follow the link to read the full article and see the video: http://www.cannabisfn.com/cannabis-companies-investors-focused-women/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Frank Lane
206-369-7050
Flane@cannabisfn.com

GlobeNewswire
globenewswire.com

Last updated on: 27/06/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.